| A Study to Investigate the Effect of Administration of Ceftazidime-avibactam (CAZ-AVI) and Ceftaroline Fosamil -Avibactam (CXL) on the Intestinal Flora of Healthy Volunteers (NCT01789528) | Pfizer | 2013-08-01 |
| EUS-guided Ethanol-lipiodol Ablation of Pancreatic Neuroendocrine Tumor: a Prospective Study (NCT01902238) | Asan Medical Center | 2013-07-01 |
| A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique (NCT01697007) | Muhimbili University of Health and Allied Sciences | 2012-11-01 |
| To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of Inhaled AZD7594 (NCT01636024) | AstraZeneca | 2012-09-01 |
| A Study to Assess the Safety, Tolerability and Effects of Single Ascending Doses of ASP3652 in Healthy Subjects (NCT01815684) | Astellas Pharma Europe B.V. | 2012-08-01 |
| Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors (NCT01576666) | Novartis Pharmaceuticals | 2012-07-01 |
| Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects (NCT02206204) | Actelion | 2012-06-01 |
| Study to Assess the Safety and the Phosphate Binding Capacity of Renazorb (NCT01560884) | Spectrum Pharmaceuticals, Inc | 2012-04-01 |
| Bioequivalence Study Comparing Arimidex Tablet and Anastrozole ODF in Japanese Healthy Male Subjects (NCT01568281) | AstraZeneca | 2012-04-01 |
| Study to Demonstrate the Safety of a Novel Powder Formulation of Lactobacilli in Adults (NCT01568567) | Good Food Practice, Sweden | 2012-03-01 |
| Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-462206 (NCT01954589) | Idorsia Pharmaceuticals Ltd. | 2011-11-01 |
| A Phase II Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants (NCT01399853) | Jiangsu Province Centers for Disease Control and Prevention | 2011-07-01 |
| The Parietal Peritoneum as a Substitute Graft for Venous Reconstruction in HPB Surgery (NCT02121886) | Beaujon Hospital | 2010-12-01 |
| Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants. (NCT01193335) | Pfizer | 2010-10-01 |
| A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Inhaled Doses Of PF-05212372. (NCT01415102) | Pfizer | 2010-09-01 |
| Single Centre, Double-blind, Single and Multiple Ascending Inhaled Doses of AZD9819 in Healthy Subjects (NCT01166698) | AstraZeneca | 2010-08-01 |
| Study Evaluating Antibody Response Of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) 24 Months After Toddler Dose. (NCT01026038) | Pfizer | 2010-04-01 |
| Phase I, Single Centre, Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043 (NCT01086813) | AstraZeneca | 2010-03-01 |
| A Study In Healthy People Of Multiple Doses Of UK-396,082 Given By Mouth, To Investigate The Safety, Toleration And Time Course Of Blood Concentration Of UK-396,082 And Its Effects. (NCT01091532) | Pfizer | 2010-03-01 |
| Safety and Pharmacokinetics of SNX-001 in Healthy Aged Volunteers (NCT01269476) | SeneXta Therapeutics SA | 2009-12-01 |
| AZD2624 Multiple Ascending Dose Study in Japan (NCT00696865) | AstraZeneca | 2008-05-01 |
| A Study to Assess the Pharmacokinetics, Safety and Tolerability of CT327 in Healthy Male Volunteers (NCT01243502) | Creabilis SA | 2007-09-01 |
| FDA Phase IV - Commitment - Retinal Function Study (NCT00461565) | Bayer | 2005-02-01 |